Chongqing University Cancer Hospital

This study tests a treatment for people with nasopharyngeal cancer that has spread to other parts of the body. The treatment combines an immunotherapy drug (tislelizumab) with chemotherapy and radiation therapy that is adjusted based on how well the tumor responds. The goal is to…

This study is for people with a specific, high-risk type of nasopharyngeal cancer (a cancer in the upper throat). All participants get the standard treatment of chemotherapy and radiation together. For those whose blood tests still show signs of the cancer virus during treatment,…